393 related articles for article (PubMed ID: 19643544)
1. Psychodynamic interpersonal therapy and improvement in interpersonal difficulties in people with severe irritable bowel syndrome.
Hyphantis T; Guthrie E; Tomenson B; Creed F
Pain; 2009 Sep; 145(1-2):196-203. PubMed ID: 19643544
[TBL] [Abstract][Full Text] [Related]
2. Patterns of interpersonal problems in irritable bowel syndrome patients: a circumplex analysis.
Lackner JM; Gurtman MB
J Psychosom Res; 2005 Jun; 58(6):523-32. PubMed ID: 16125519
[TBL] [Abstract][Full Text] [Related]
3. Reported sexual abuse predicts impaired functioning but a good response to psychological treatments in patients with severe irritable bowel syndrome.
Creed F; Guthrie E; Ratcliffe J; Fernandes L; Rigby C; Tomenson B; Read N; Thompson DG
Psychosom Med; 2005; 67(3):490-9. PubMed ID: 15911915
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients.
Mearin F; Badía X; Balboa A; Benavent J; Caballero AM; Domínguez-Muñoz E; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
Aliment Pharmacol Ther; 2006 Mar; 23(6):815-26. PubMed ID: 16556184
[TBL] [Abstract][Full Text] [Related]
5. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
[TBL] [Abstract][Full Text] [Related]
6. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.
Hertig VL; Cain KC; Jarrett ME; Burr RL; Heitkemper MM
Nurs Res; 2007; 56(6):399-406. PubMed ID: 18004186
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome.
Creed F; Fernandes L; Guthrie E; Palmer S; Ratcliffe J; Read N; Rigby C; Thompson D; Tomenson B;
Gastroenterology; 2003 Feb; 124(2):303-17. PubMed ID: 12557136
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome.
van der Veek PP; van Rood YR; Masclee AA
Aliment Pharmacol Ther; 2007 Sep; 26(6):943-52. PubMed ID: 17767479
[TBL] [Abstract][Full Text] [Related]
9. [Does improvement of symptoms four weeks after the begin of psychodynamic inpatient psychotherapy correspond to long term outcome?].
Franke GH; Hoffmann T; Frommer J
Z Psychosom Med Psychother; 2005; 51(4):360-72. PubMed ID: 16402334
[TBL] [Abstract][Full Text] [Related]
10. A course of instruction for women with irritable bowel syndrome.
Bengtsson M; Ulander K; Börgdal EB; Christensson AC; Ohlsson B
Patient Educ Couns; 2006 Jul; 62(1):118-25. PubMed ID: 16098703
[TBL] [Abstract][Full Text] [Related]
11. The effect of trimebutine on the psychosocial adjustment to illness in the irritable bowel syndrome.
Dumitraşcu DL; Stănculete M
Rom J Intern Med; 2006; 44(3):273-80. PubMed ID: 18386606
[TBL] [Abstract][Full Text] [Related]
12. [Psychological aspects of psychosomatic pathology of large intestine].
Vashadze ShV
Georgian Med News; 2009 Jun; (171):37-40. PubMed ID: 19578211
[TBL] [Abstract][Full Text] [Related]
13. Psychological influences on the irritable bowel syndrome.
Lea R; Whorwell PJ
Minerva Med; 2004 Oct; 95(5):443-50. PubMed ID: 15467519
[TBL] [Abstract][Full Text] [Related]
14. Subjective health complaints and quality of life in patients with irritable bowel syndrome following Giardia lamblia infection: a case control study.
Morken MH; Lind RA; Valeur J; Wilhelmsen I; Berstad A
Scand J Gastroenterol; 2009; 44(3):308-13. PubMed ID: 19031266
[TBL] [Abstract][Full Text] [Related]
15. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial.
Vlieger AM; Menko-Frankenhuis C; Wolfkamp SC; Tromp E; Benninga MA
Gastroenterology; 2007 Nov; 133(5):1430-6. PubMed ID: 17919634
[TBL] [Abstract][Full Text] [Related]
16. Why do subjects with irritable bowel syndrome seek health care for their symptoms?
Ringström G; Abrahamsson H; Strid H; Simrén M
Scand J Gastroenterol; 2007 Oct; 42(10):1194-203. PubMed ID: 17852851
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study.
Brennan BP; Fogarty KV; Roberts JL; Reynolds KA; Pope HG; Hudson JI
Hum Psychopharmacol; 2009 Jul; 24(5):423-8. PubMed ID: 19548294
[TBL] [Abstract][Full Text] [Related]
18. Nuances in treating irritable bowel syndrome.
Frissora CL
Rev Gastroenterol Disord; 2007; 7(2):89-96. PubMed ID: 17597676
[TBL] [Abstract][Full Text] [Related]
19. Anger, interpersonal relationships, and health-related quality of life in bullying boys who are treated with outpatient family therapy: a randomized, prospective, controlled trial with 1 year of follow-up.
Nickel MK; Krawczyk J; Nickel C; Forthuber P; Kettler C; Leiberich P; Muehlbacher M; Tritt K; Mitterlehner FO; Lahmann C; Rother WK; Loew TH
Pediatrics; 2005 Aug; 116(2):e247-54. PubMed ID: 16061577
[TBL] [Abstract][Full Text] [Related]
20. Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care.
Reme SE; Kennedy T; Jones R; Darnley S; Chalder T
J Psychosom Res; 2010 Apr; 68(4):385-8. PubMed ID: 20307706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
